Fujii Kanako, Hirano Makito, Terayama Atsushi, Inada Rino, Saito Yoshihiko, Nishino Ichizo, Nagai Yoshitaka
Department of Neurology, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.
Department of Neurology, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.
Neuromuscul Disord. 2022 May;32(5):436-440. doi: 10.1016/j.nmd.2022.01.009. Epub 2022 Jan 31.
Mutations in MEGF10 are associated with early-onset myopathy, areflexia, respiratory distress, and dysphagia (EMARDD). Recently, a mild variant phenotype of EMARDD has been reported in patients with multiple minicores in the myofibers. However, some reported patients had no clear cores. We present a patient who had progressive weakness since his 30 s and then developed severe respiratory failure at the age of 66 years and found that he had a novel mutation, p.G739R, in MEGF10. He had no clear core in the biopsied muscle. We summarize the clinical and genetic characteristics of the current and reported patients with MEGF10 and statistically evaluate the genotype-phenotype correlation. Results show that patients with missense mutations in at least one allele had significantly later onset than those with biallelic truncation mutations.
MEGF10基因的突变与早发性肌病、无反射、呼吸窘迫和吞咽困难(EMARDD)相关。最近,在肌纤维中有多个微小核心的患者中报告了EMARDD的一种轻度变异表型。然而,一些报告的患者没有明显的核心。我们报告了一名患者,他从30多岁开始逐渐出现肌无力,66岁时发展为严重呼吸衰竭,发现其MEGF10基因有一个新的突变p.G739R。他活检的肌肉中没有明显的核心。我们总结了当前和已报告的MEGF10患者的临床和遗传特征,并对基因型-表型相关性进行了统计学评估。结果显示,至少一个等位基因有错义突变的患者发病时间明显晚于双等位基因截短突变的患者。